AEVIS (AEVIS) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
17 Jun, 2026Executive summary
Achieved strong performance in 2024, marked by significant deleveraging, successful investment activity, and value creation across healthcare, hospitality, and real estate segments.
Statutory net profit reached CHF 26.5 million, reversing a prior year loss of CHF 8.8 million, with equity rising to CHF 573.4 million and an equity ratio of 70.1%.
Opened the Genolier Innovation Hub and completed key acquisitions, including Spital Zofingen and Centro Medico, expanding integrated care regions.
Hospitality segment delivered another record year with over 10% growth, and infrastructure portfolio remained stable with strategic asset sales.
Strategic partnerships, such as with Kantonsspital Aarau and Visana, enhanced integrated care and insurance offerings.
Financial highlights
Net profit reached CHF 26.5 million in 2024, reversing a prior year loss of CHF 8.8 million.
Equity increased to CHF 573.4 million (70.1% of assets), up from CHF 549.3 million (68.3%) year-over-year.
Book value of participations at CHF 656 million, with market value exceeding CHF 2 billion, indicating substantial hidden reserves.
Hospitality segment achieved organic growth of 10.1%, with revenue per room up 8.5% and average room rates at CHF 580.
Real estate EBITDA increased by 26%, and Infracore’s market value rose to over CHF 1.33 billion.
Outlook and guidance
Strong start to 2025 with 24.7% revenue growth in healthcare in the first two months, driven by acquisitions and 4% organic growth.
Continued focus on integration of new acquisitions and expansion of integrated care regions, with a third region planned for 2026.
Ongoing cost-cutting and efficiency programs are on track, with more than half of CHF 20 million savings already achieved.
No consolidated revenue or margin targets provided for 2025 due to macroeconomic uncertainties and investment diversity.
Dividend payments expected to resume from 2025, with 2024 profits prioritized for deleveraging.
Latest events from AEVIS
- Integrated healthcare, hospitality, and real estate drive growth, margin gains, and long-term value.AEVIS
CMD 2026 presentation2 Jun 2026 - Acquisition for CHF 50M in shares and CHF 70M debt drives CHF 100M revenue boost in 2025.AEVIS
M&A announcement26 May 2026 - Revenue up 13.5% to CHF 1,055.1m, with deleveraging and margin improvement across segments.AEVIS
H2 202526 May 2026 - Revenue and EBITDAR surged, with net profit rebounding and strong segment growth.AEVIS
H1 202426 May 2026 - Revenue grew 7.1% year-over-year, driven by strong healthcare, hospitality, and real estate gains.AEVIS
Q3 202426 May 2026 - Q1 2025 revenue rose 17.0% year-over-year, led by healthcare and hospitality growth.AEVIS
Q1 202526 May 2026 - H1-2025 saw revenue up 17.9%, strong margins, and debt cut by over CHF 120m.AEVIS
H1 202526 May 2026 - Revenue up 18.2% year-over-year, with strong growth in Healthcare, Hospitality, and Real Estate.AEVIS
Q3 202526 May 2026 - Q1 2026 saw strong growth in rental income and profitability, with robust outlook for the year.AEVIS
Q1 202626 May 2026